Runway Growth Finance Corp. Announces Date for Fourth
WOODSIDE, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth”), a
Globe Newswire9-02-2023, 04:17
Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well as 2-11-2024, 02:00